Schrödinger to Present Preclinical Data at AACR Annual Meeting
Schrödinger today announced that new preclinical data on SGR-3515 and SGR-4174 will be presented at the AACR Annual Meeting ...
Le Lézard8h
FORE Biotherapeutics to Present Two Plixorafenib Abstracts at the American Association for Cancer Research Annual Meeting 2025
FORE Biotherapeutics, a registration stage biotherapeutics company dedicated to developing targeted therapies to treat patients with cancer, today announced two plixorafenib abstracts have been ...
Le Lézard8h
Shadow Power Announces OpenADR 2.0b Compliance
Shadow Power, a leader in customer energy resource (CERs) management, proudly announces that its platform is now OpenADR 2.0b certified. This milestone reinforces Shadow Power's ability to transform ...